Atlas Trials

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Clinical trial NCT02561273 · COMPLETED

Trial details

NCT number
NCT02561273
Sponsor
University of Nebraska
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedStage II Angioimmunoblastic T-cell LymphomaStage II Enteropathy-Associated T-Cell LymphomaStage III Angioimmunoblastic T-cell LymphomaStage III Enteropathy-Associated T-Cell LymphomaStage IV Angioimmunoblastic T-cell LymphomaStage IV Enteropathy-Associated T-Cell Lymphoma
Start date
2015-09-28
Primary completion
2019-11-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.